focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 370.00
Bid: 365.00
Ask: 380.00
Change: 5.00 (1.37%)
Spread: 15.00 (4.11%)
Open: 356.00
High: 380.00
Low: 356.00
Prev. Close: 365.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Letter to icapital.biz Berhad

15 Sep 2016 09:46

RNS Number : 9378J
City of London Investment Group PLC
15 September 2016
 

CITY OF LONDON INVESTMENT GROUP PLC

 

TEXT OF LETTER TO ICAPITAL.BIZ BERHAD

 

(LONDON, 15 September, 2016) - City of London Investment Management has sent a letter (published in full below) to the board of icapital.biz Berhad (ICAP:MK) explaining its intention to oppose the re-election of directors at ICAP's forthcoming AGM.

 

Background

City of London Investment Group is an emerging markets fund manager which specialises in investing in closed-end investment companies. The firm is authorised and regulated by the Financial Conduct Authority and registered as an Investment Advisor with the Securities and Exchange Commission.

 

 

For further information, please contact:

 

Simon Westlake

City of London Investment Group

020 7711 1552

simon.westlake@citlon.co.uk 

 

 

Full text of letter

 

 

The Directors

icapital.biz Berhad

Unit 30-01, Level 30, Tower A

Vertical Business Suite

Avenue 3, Bangsar South

No. 8, Jalan Kerinchi

59200 Kuala Lumpur

Malaysia

 

 

15th September 2016

 

 

Dear Directors,

 

Twelfth Annual General Meeting of icapital.biz Berhad (ICAP)

 

Clients of City of London Investment Management Limited (CLIM) own 21,970,900 ICAP shares (15.7%). There has been no action in response to any of the points that were raised in our letter to you dated 26th August 2015, which set out our concerns regarding ICAP's poor performance and persistently wide discount to NAV. CLIM therefore confirms that it intends to continue voting against the re-election of incumbent directors. Accordingly, CLIM intends to vote against the re-election of Madam Leong So Seh at ICAP's 12th AGM on Saturday, 24th September 2016.

 

 

· Performance

We reiterate our call for performance comparisons in shareholder communications to be made on a total return basis, which is universally accepted in the investment industry as best practice.

 

The total return in the five years to end May 2016 for the FTSE Bursa Malaysia Index has been 23.1% cumulative (equivalent to 4.2% pa). In comparison ICAP's NAV return has been 13.0% cumulative (2.5% pa). The share price return over this period has been even worse due to discount widening, at 6.4% cumulative (1.3% pa). These performance figures have been sourced from Bloomberg.

 

The Chairman stated, in his letter to shareholders, dated 19th July 2016, that ICAP has 'performed beyond expectations'. We wish to make clear that ICAP's performance over the past five years has fallen significantly short of our own expectations.

 

· Cash Management

We note the continued extraordinarily high cash level, which has persisted at over 50% for 3 years and on which shareholders have been paying fees for fund management and investment research services. Cash at each calendar year end since ICAP was launched (31 December 2005 to 31 December 2015) has averaged 39%. ICAP is clearly operating with surplus cash which, in our opinion should be returned to shareholders.

 

· Expense Ratio

ICAP's expense ratio in 2016 was 1.9% (2015: 1.9%) which compares unfavourably with other country specific closed-end funds. The most significant item is the aggregate 1.5% incurred for fund management and investment research. CLIM urges the Board to negotiate competitive fees in order to reduce the expense ratio to an acceptable level.

 

· Discount Control

ICAP's prospectus dated 26 September 2005 explained clearly that the return for closed-end fund investors is a product of NAV performance and the discount movement. The Chairman's letter to Shareholders in the 2016 Annual Report refers to a 4% rise in ICAP's NAV for the 12 months ended 31 May 2016. However it does not mention that the share price actually declined over this period, because the discount widened. The discount averaged 22% in 2016 versus 20% in 2015 (source: Bloomberg). Neither the level nor the trend is acceptable and CLIM is disappointed that the Board has again failed to take any action to address this problem.

 

CLIM notes from the 2016 Annual Report the Board's deliberations on 27th July 2015 regarding share buy-backs and the accompanying statement that the "Fund's NAV could deteriorate if it uses its available fund to purchase own shares". Repurchasing shares at a discount to NAV will actually increase the NAV per share and in CLIM's opinion this would be a sensible use of ICAP's cash, particularly in view of the Manager's apparent shortage of investment ideas.

 

ICAP's prospectus included a section (6.7, page 64) on managing discounts, noting that the options available include 'share repurchase, open-ending, takeover, liquidation'. CLIM urges the Board to consider all these options and to formulate a strategy to reduce the discount from its present unacceptable level.

 

 

 

Yours sincerely,

 

Simon Westlake

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUGWBUPQURA
Date   Source Headline
4th Jan 20169:55 amRNSBlocklisting Interim Review
31st Dec 201512:40 pmRNSSecond Price Monitoring Extn
31st Dec 201512:35 pmRNSPrice Monitoring Extension
15th Dec 201510:41 amRNSShare Buy Back
30th Nov 20152:27 pmRNSHolding(s) in Company
10th Nov 20154:31 pmRNSDirector/PDMR Shareholding
21st Oct 20154:52 pmRNSPDMR Share Holding/Share Buy Back
20th Oct 20154:05 pmRNSHardman & Co issues research report
19th Oct 20154:36 pmRNSResult of AGM
19th Oct 20157:00 amRNSAGM Trading Update
8th Oct 20156:01 pmRNSHardman & Co issues research
8th Oct 20157:00 amRNSInterim Management Statement
15th Sep 201511:18 amRNSHardman & Co issues research report
14th Sep 20157:00 amRNSFinal Results
1st Sep 20154:35 pmRNSPrice Monitoring Extension
28th Aug 201512:04 pmRNSText of letter to icapital.biz Berhad
25th Aug 20157:00 amRNSDividend Timetable
21st Aug 20157:00 amRNSBoard Changes
16th Jul 20153:08 pmRNSHardman & Co issues research report
15th Jul 20157:00 amRNSTrading Update
2nd Jul 20153:56 pmRNSBlocklisting Interim Review
19th Jun 20154:07 pmRNSDirector/PDMR Shareholding
17th Apr 20153:03 pmRNSDirector/PDMR Shareholding
8th Apr 20157:00 amRNSInterim Management Statement
18th Feb 20154:58 pmRNSDirector/PDMR Shareholding
11th Feb 20157:00 amRNSInterim Results
6th Jan 20157:00 amRNSFUNDS UNDER MANAGEMENT AT 31/12/14 TRADING UPDATE
2nd Jan 20157:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
19th Dec 201410:56 amRNSHolding(s) in Company
12th Dec 20149:15 amRNSShare Buyback and Total Voting Rights
11th Dec 20149:18 amRNSShare Buyback and Total Voting Rights
13th Nov 20143:43 pmRNSShare Buyback and Total Voting Rights
3rd Nov 20148:54 amRNSShare Buy Back and Total Voting Rights
22nd Oct 20145:17 pmRNSResult of AGM
22nd Oct 20147:00 amRNSInterim Management Statement
8th Oct 20149:14 amRNSHolding(s) in Company
15th Sep 20147:00 amRNSFinal Results
15th Jul 20147:00 amRNSTrading Update
1st Jul 20147:00 amRNSBlocklisting Interim Review
22nd May 20144:35 pmRNSPrice Monitoring Extension
25th Apr 20145:06 pmRNSHolding(s) in Company
5th Mar 201411:41 amRNSDirector/PDMR Shareholding
4th Mar 20147:00 amRNSQuarterly Funds under Management ("FuM") Update
20th Jan 20147:00 amRNSHalf Yearly Results
2nd Jan 20142:13 pmRNSBlocklisting Interim Review
2nd Dec 20137:00 amRNSTrading Update
8th Oct 20134:10 pmRNSResult of AGM
7th Oct 20137:00 amRNSInterim Management Statement
13th Sep 201310:02 amRNSHolding(s) in Company
12th Sep 201310:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.